Tuesday, February 25, 2014 10:46:45 AM
http://ir.stockpr.com/oncosec/company-news/detail/1284/oncosec-medical-to-present-at-24th-annual-wall-street-analyst-forum-institutional-investor-conference
SAN DIEGO-- OncoSec Medical Inc. (OTCQB: ONCS), a company developing its advanced-stage ImmunoPulse DNA-based immunotherapy to treat solid tumors, today announced that Punit Dhillon, President and CEO, will present a corporate overview of the company at the 24th Annual Wall Street Analyst Forum Institutional Investor Conference at the University Club in New York, New York on Monday, March 3rd at 12:05 p.m. (EST).
At the time of the presentation, a live webcast of OncoSec’s presentation will be available at the following link: http://www.visualwebcaster.com/event.asp?id=98095
OncoSec recommends registering at least 10 minutes prior to the start of the presentation to ensure timely access. Participants will require Windows Media Player (a free download is available from the presentation link) in order to participate. After the presentation, an archived version of the webcast will be available on OncoSec’s web page at http://www.oncosec.com under the “Events” tab.
About the Wall Street Analyst Forum Institutional Investor Conference
Since 1989, the Wall Street Analyst Forum has conducted over 80 multiday/multitrack analyst conferences in Boston, New York, and London; in which over 2500 different NYSE/NASDAQ/AMEX/OTC companies have presented, and over 2000 different institutions have attended. Analysts and portfolio managers from the vast majority of money management firms attend its conferences either in person or via webcast, and past presenters have included such companies as General Electric, Pfizer, Microsoft Corp, and Mattel. In 1998, WSAF received extensive coverage in the financial press for conducting the first live webcast of individual corporate meetings from an investor conference. The 24th Annual Institutional Investor Conference will take place March 3-4, 2014 at the University Club in New York City.
Recent ONCSQ News
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/13/2024 07:30:19 PM
CBD Life Sciences Inc. (CBDL) Launches High-Demand Mushroom Gummy Line for Targeted Wellness Needs, Tapping into a Booming $20 Billion Market • CBDL • Oct 31, 2024 8:00 AM
Nerds On Site Announces Q1 Growth and New Initiatives for the Remainder of 2024 • NOSUF • Oct 31, 2024 7:01 AM
Innovation Beverage Group Receives Largest Shipment of its Top-Selling Bitters to Date in the U.S.-Ready to Meet Growing Demand from Expanding Distribution Network • IBG • Oct 30, 2024 12:22 PM
Element79 Gold Corp to Update Investors on the Emerging Growth Conference on October 31, 2024 • ELMGF • Oct 30, 2024 9:08 AM
CBD Life Sciences Inc. (CBDL) Announces Grand View Research Report Findings on High - Growth CBD Equine Market, Aiming to Drive Unprecedented Shareholder Value • CBDL • Oct 29, 2024 10:19 AM
Integrated Ventures Announces Partnership And Lease Agreement with Driptide Wellness - Leading Health and Wellness Provider. • INTV • Oct 29, 2024 8:45 AM